Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

507
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
507
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

1.1K
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.1K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Increased risk of <i>de novo</i> inflammatory bowel disease following cholecystectomy: a population-based analysis.

Annals of gastroenterology·2026
Same author

Glucagon-Like Peptide-1 Receptor Agonists in Inflammatory Bowel Disease: A Narrative Review.

Gastro hep advances·2026
Same author

Risk of Myeloproliferative Neoplasms in Patients With Inflammatory Bowel Disease and Impact on Outcomes: A Multi-Centre Matched Analysis.

Alimentary pharmacology & therapeutics·2026
Same author

Respiratory syncytial virus incidence and clinical outcomes in patients with inflammatory bowel disease: a National Veterans Affairs cohort study.

Inflammatory bowel diseases·2026
Same author

Outcomes in adult liver transplant patients receiving recombinant herpes zoster vaccine.

Vaccine·2026
Same author

Guidelines in Practice: Preventive Care in Inflammatory Bowel Disease.

The American journal of gastroenterology·2026

相关实验视频

Updated: Jan 8, 2026

Author Spotlight: Developing a Rat Model for Pouchitis Research and Treatment
04:05

Author Spotlight: Developing a Rat Model for Pouchitis Research and Treatment

Published on: May 31, 2024

798

异常的MUC1表达作为炎的生物标志物

Caroline G Olson1, Fadi F Francis1, Irene K Yan2,3

  • 1Division of Gastroenterology and Hepatology, Mayo Clinic, 4500 San Pablo Rd, Jacksonville, FL, USA.

Digestive diseases and sciences
|December 21, 2025
PubMed
概括

异常的MUC1糖蛋白在性结肠炎 (UC) 患者中过度表达,这些患者在阴茎-门解剖后 (IPAA) 患有囊炎. 这种异常的MUC1随着囊炎的严重程度而增加,可能作为生物标志物.

关键词:
在MUC1中,MUC1是MUC1.皮囊炎 (Pouchitis) 是一种疾病.性结肠炎是一种

更多相关视频

Important Endpoints and Proliferative Markers to Assess Small Intestinal Injury and Adaptation using a Mouse Model of Chemotherapy-Induced Mucositis
07:05

Important Endpoints and Proliferative Markers to Assess Small Intestinal Injury and Adaptation using a Mouse Model of Chemotherapy-Induced Mucositis

Published on: May 12, 2019

6.5K
Technique of Conjunctival Biopsy and Direct Immunofluorescence for Diagnosing Mucous Membrane Pemphigoid
05:05

Technique of Conjunctival Biopsy and Direct Immunofluorescence for Diagnosing Mucous Membrane Pemphigoid

Published on: June 17, 2025

925

相关实验视频

Last Updated: Jan 8, 2026

Author Spotlight: Developing a Rat Model for Pouchitis Research and Treatment
04:05

Author Spotlight: Developing a Rat Model for Pouchitis Research and Treatment

Published on: May 31, 2024

798
Important Endpoints and Proliferative Markers to Assess Small Intestinal Injury and Adaptation using a Mouse Model of Chemotherapy-Induced Mucositis
07:05

Important Endpoints and Proliferative Markers to Assess Small Intestinal Injury and Adaptation using a Mouse Model of Chemotherapy-Induced Mucositis

Published on: May 12, 2019

6.5K
Technique of Conjunctival Biopsy and Direct Immunofluorescence for Diagnosing Mucous Membrane Pemphigoid
05:05

Technique of Conjunctival Biopsy and Direct Immunofluorescence for Diagnosing Mucous Membrane Pemphigoid

Published on: June 17, 2025

925

科学领域:

  • 胃肠病学 胃肠病学
  • 免疫学 免疫学 免疫学
  • 分子生物学分子生物学

背景情况:

  • 在性结肠炎 (UC) 患者中,炎是经过阴道-口袋解体 (IPAA) 后的常见并发症.
  • 在炎症期间发生MUC1糖蛋白的异常糖化,可能会破坏粘液屏障.
  • 了解MUC1的表达模式可以阐明炎的病原性.

研究的目的:

  • 为了研究不同程度的囊炎的UC患者的囊粘膜中MUC1表达模式.
  • 为了比较UC患者的MUC1表达与家族腺瘤多发症 (FAP) 患者的UC1表达.

主要方法:

  • 来自UC/IPAA和FAP/IPAA患者的档案J袋活检的分析.
  • 对于异常低糖化MUC1.1的免疫组织化学染色.
  • 炎症的组织学分类使用南希组织学指数.

主要成果:

  • 在UC/IPAA患者中,与FAP/IPAA患者相比,观察到异常高的低糖化MUC1表达显著增加.
  • 在UC患者中,MUC1表达水平与囊炎的严重程度呈正相关性.
  • 在没有囊炎的患者或患有FAP的患者中检测到最小异常的MUC1.

结论:

  • 异常的低糖化MUC1在UC患者的乳腺粘膜中过度表达.
  • 过度表达MUC1的程度与囊炎的严重程度成正比.
  • 低糖化MUC1显示出作为严重囊炎的生物标志物的潜力.